Sana Biotechnology Inc vs Snap Inc — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Snap Inc trades at $4.57 (market cap $7.67B). The key difference: Snap Inc is far larger — about 8.8× Sana Biotechnology Inc's market cap. Which is the better fit depends on your goals.
| SANA | SNAP | |
|---|---|---|
Market Cap | $873.84M | $7.67B |
Sector | Health | Media |
52-Week High | $5.92 | $10.35 |
52-Week Low | $2.68 | $3.93 |
Enterprise Value | $848.03M | $9.05B |
Trailing returns across standard periods
Latest headlines on both assets
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →Snap, which refers to itself as a camera company, has one of the most popular social networking apps, Snapchat, in developed regions such as North America and Europe. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S. The firm is headquartered in Venice, California.
Read more on SNAP →